ARCHIVES

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010

GAO: FDA Data On Drug Shortages Inadequate

February 21, 2014

In Brief: Senate Subcommittee Recommends $1 .52 Billion

September 25, 1987

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

CPRIT Likely to Get Funding For Two Years; DePinho Announces Austerity Measures

May 17, 2013

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014